Showing 1,321 - 1,330 of 1,415
Persistent link: https://www.econbiz.de/10012490508
Persistent link: https://www.econbiz.de/10012490998
Persistent link: https://www.econbiz.de/10012494002
Persistent link: https://www.econbiz.de/10012542773
Persistent link: https://www.econbiz.de/10012616315
Persistent link: https://www.econbiz.de/10012601606
Persistent link: https://www.econbiz.de/10012495296
Persistent link: https://www.econbiz.de/10012807964
Background: Although endovascular therapy (EVT) improves clinical outcomes in patients with acute ischemic stroke, the time of EVT initiation significantly influences clinical outcomes and healthcare costs. This study evaluated the impact of EVT treatment delay on cost-effectiveness in China....
Persistent link: https://www.econbiz.de/10012804283
Introduction: Until recently, adjuvant treatment options for higher stage resectable cutaneous melanoma were limited. Two studies with a similar set-up, published 2017, led to registration of targeted therapy for BRAF-mutated melanoma with dabrafenib and trametinib as well as of the...
Persistent link: https://www.econbiz.de/10012804643